Clinical Trials · NCT00799435
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Baylor College of Medicine
- Enrollment
- 2
- Start date
- Jul 2009
- Locations
- 1 site, United States
- Primary endpoint
- Change in Aortic Stiffness, as Measured by the Change in the Mean Aortic Pulse Wave Velocity